AiCure logo
Verified via Expert Interviews

AiCure: Revenue, Valuation & Competitors

AiCure company overview

Ownership
PE-backed
Employees
55
Investors
Palisades Growth Capital
Revenue / FTE
$4••k

About

AI-powered patient engagement and behavioral monitoring platform for clinical trials and life sciences organizations to confirm medication adherence, capture eCOA/ePRO, and predict dropout risk.
USA
Global
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former AiCure executives.

Ownership & Key Financials

Revenue

- '••
2

Investors

Palisades Growth Capital
'19
1

Revenue / FTE

$4••k '••
2

Ownership

PE-backed
1

FTEs

2
+1% CAGR
78
2020
91
2021
101
2022
78
2023
55
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.